VANGUARD GROUP INC - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$76,315,726
-22.2%
11,704,866
-0.9%
0.00%
-50.0%
Q1 2024$98,070,053
-16.4%
11,815,669
+10.9%
0.00%
-33.3%
Q4 2023$117,260,761
+32.1%
10,650,387
+0.9%
0.00%
+50.0%
Q3 2023$88,745,365
-32.9%
10,552,362
+0.2%
0.00%
-33.3%
Q2 2023$132,238,801
-23.5%
10,528,567
+0.3%
0.00%
-25.0%
Q1 2023$172,926,995
+11.5%
10,499,514
+1.1%
0.00%0.0%
Q4 2022$155,140,217
-17.0%
10,384,218
+24.2%
0.00%
-33.3%
Q3 2022$187,003,000
+57.3%
8,359,520
+17.8%
0.01%
+100.0%
Q2 2022$118,900,000
-36.1%
7,098,454
+14.2%
0.00%
-25.0%
Q1 2022$186,093,000
-2.2%
6,217,623
+0.3%
0.00%0.0%
Q4 2021$190,354,000
+23.6%
6,198,442
+26.9%
0.00%0.0%
Q3 2021$153,994,000
-2.0%
4,884,037
+13.8%
0.00%0.0%
Q2 2021$157,096,000
+12.2%
4,293,442
+6.0%
0.00%0.0%
Q1 2021$140,046,000
+95.8%
4,051,081
+135.4%
0.00%
+100.0%
Q4 2020$71,511,000
+2.9%
1,720,675
+5.4%
0.00%0.0%
Q3 2020$69,506,0001,631,9740.00%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 5,998,574$75,342,0896.58%
Nextech Invest Ltd. 948,659$11,915,1574.05%
MPM BioImpact LLC 1,354,368$17,010,8623.42%
Finepoint Capital LP 701,570$8,811,7193.05%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$350,486,3352.67%
EcoR1 Capital, LLC 4,163,824$52,297,6291.28%
BVF INC/IL 3,120,521$39,193,7441.09%
Integral Health Asset Management, LLC 700,000$8,792,0001.09%
Boxer Capital, LLC 1,819,132$22,8481.06%
Alphabet Inc. 1,568,753$19,703,5371.06%
View complete list of RELAY THERAPEUTICS INC shareholders